Pain Patches Market Analysis

  • Report ID: 5783
  • Published Date: May 09, 2025
  • Report Format: PDF, PPT

Pain Patches Segmentation

Product Type (Non-Opioid Patches, Opioid Patches)

In pain patches market, non-opioid patches segment is likely to dominate around 60% share by the end of 2037. The increasing demand for opioid substitutes that not only efficiently treat pain but also do so without the risks is accelerating the demand for non-opioid patches. It is also used to provide long-term, efficient medication administration while also easing discomfort. They also avoid the first-pass metabolism and prevent users from becoming addicted to drugs, making them more efficient at delivering pharmaceuticals. Therefore, the market is anticipated to increase as a result of the product's capacity to relieve pain without having the negative effects associated with opioids and other variables. As per the Association for Safe International Travel, over 4.4 million people in the United States needed medical attention due to severe injuries in 2020.

Type (Prescription Medicine, OTC Medicine)

In pain patches market, prescription medicine segment is predicted to dominate around 53% revenue share by the end of 2037. This is because individuals with a broad spectrum of medical conditions may be prescribed pain patches by medical practitioners. They are also commonly used to treat a variety of different types of pain, including knee discomfort, nerve pain, and back pain. Due to its authorization by medical professionals, its use in treating pain from a variety of conditions with little to no negative effects on the patient will accelerate the segment's growth.

Our in-depth analysis of the pain patches market includes the following segments:

            Product Type

  • Non-Opioid Patches
  • Opioid Patches

            Type

  • Prescription Medicine
  • OTC Medicine

            Distribution Channel

  • Drug Store & Retail Pharmacies
  • Hospital Pharmacies
  • Online Providers

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

Pain Patches Market in 2025 is evaluated at USD 5.6 billion.

The global market size crossed USD 5.39 billion in 2024 and is likely to register a CAGR of over 4.9%, exceeding USD 10.04 billion revenue by 2037.

North America is estimated to record USD 3.21 billion by 2037, driven by rising number of people participating in sports and fitness activities, leading to an increased demand for pain relief treatments.

The major players in the market include Endo, Inc., Johnson and Johnson Private Limited, Sorrento Therapeutics, Inc., Amneal Pharmaceuticals LLC, Purdue Pharma L.P., Teva Pharmaceutical Industries Ltd., Grunenthal GmbH, NEXGEL, Inc., Viatris Inc., Pfizer Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos